{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-114376","form_type":"8-K","ticker":"NVAX","cik":"0001000694","company_name":"NOVAVAX INC","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.286902+00:00","generated_at":"2026-05-30T05:03:51.593375+00:00","sec_items":["1.01","1.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Novavax settles UK COVID vaccine supply dispute, agrees to pay $123.8M refund","bullets":["Settlement with UK Health Security Agency resolves all claims related to the Amended and Restated Supply Agreement.","Company to pay $123.8M in equal quarterly installments of $10.3M over three years, ending June 30, 2027.","First installment of $10.3M due November 30, 2024 under a Letter of Amendment.","Total includes $11.3M imputed interest; company may avoid interest by accelerating payments.","Original supply agreement terminated effective November 1, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-114376","json":"https://secwatch.observer/filing/0001104659-24-114376.json","markdown":"https://secwatch.observer/filing/0001104659-24-114376.md","text":"https://secwatch.observer/filing/0001104659-24-114376.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924114376/0001104659-24-114376-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924114376/tm2427595d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:03:51.593375+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}